Nanotechnology: Pioneering Drug Discovery and Delivery Innovations

D. Manju Bhargavi, Ch. Kavyasri and V. Jeevana Jyothi

Chapter 23 in Convergence of Technology & Biology ─ Transforming Life Sciences, 2025, pp 255-262 from Shanlax Publications

Abstract: Nanomaterials have revolutionized the field of drug discovery and delivery by enabling targeted, efficient, and controlled release of therapeutics. This review explores the role of nanotechnology in drug development, with a focus on nanocarriers such as liposomes, dendrimers, polymeric nanoparticles, and inorganic nanomaterials. Key advantages include improved bioavailability, reduced side effects, and enhanced therapeutic efficacy. Several case studies highlight the success of nanomaterials in treating diseases like cancer, neurodegenerative disorders, and infectious diseases. The literature survey examines recent advancements and challenges in the clinical translation of nanomedicines. While nanotechnology offers immense potential in pharmaceutical sciences, concerns related to toxicity, scalability, and regulatory approval must be addressed for widespread adoption. This review underscores the need for interdisciplinary research to further harness the benefits of nanotechnology in medicine.

Date: 2025
ISBN: 978-93-6163-763-6
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.shanlaxpublications.com/p/ctbtls/ch023.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dax:ctbtls:978-93-6163-763-6:p:255-262

Access Statistics for this chapter

More chapters in Convergence of Technology & Biology ─ Transforming Life Sciences from Shanlax Publications Madurai, Tamil Nadu, India.
Bibliographic data for series maintained by S.Lakshmanan ().